|
Volumn 133, Issue 6 SUPPL. 6, 2008, Pages 71S-109S
|
Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
|
Author keywords
Guidelines; Recommendations
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ALTEPLASE;
AMIODARONE;
ANTICOAGULANT AGENT;
ANTIVITAMIN K;
ARGATROBAN;
CLOPIDOGREL;
DANAPAROID;
DESULFATOHIRUDIN;
DICLOFENAC;
DIPYRIDAMOLE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FONDAPARINUX;
HEPARIN;
HEPARINOID;
HIRULOG;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENTOXIFYLLINE;
PHENPROCOUMON;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
STREPTOKINASE;
SULODEXIDE;
THROMBIN INHIBITOR;
TICLOPIDINE;
UNINDEXED DRUG;
VITAMIN K GROUP;
WARFARIN;
ANAPHYLAXIS;
ANTICOAGULATION;
BLEEDING;
CARDIOVERSION;
CEREBRAL SINUS THROMBOSIS;
CEREBROVASCULAR ACCIDENT;
CONTINUOUS INFUSION;
EMBOLECTOMY;
FIBRINOLYTIC THERAPY;
GASTROINTESTINAL HEMORRHAGE;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM FLUTTER;
HEPARIN INDUCED THROMBOCYTOPENIA;
HIGH RISK PATIENT;
HIGH RISK POPULATION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LEG THROMBOSIS;
LEG ULCER;
LOADING DRUG DOSE;
LOW DRUG DOSE;
LUNG EMBOLISM;
PARTIAL THROMBOPLASTIN TIME;
PERCUTANEOUS CORONARY INTERVENTION;
PERIOPERATIVE PERIOD;
POSTTHROMBOSIS SYNDROME;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK BENEFIT ANALYSIS;
THROMBOCYTE COUNT;
THROMBOEMBOLISM;
THROMBOPHLEBITIS;
VALVULAR HEART DISEASE;
VENA CAVA FILTER;
VENOUS THROMBOEMBOLISM;
ANTICOAGULANTS;
EVIDENCE-BASED MEDICINE;
HUMANS;
PERIOPERATIVE CARE;
PLATELET COUNT;
|
EID: 45949101991
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.08-0693 Document Type: Article |
Times cited : (324)
|
References (0)
|